Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 8,253Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Taro Pharmaceutical Industries

02 1Alembic Pharmaceuticals Limited

03 1Amneal Pharmaceuticals

04 1Chartwell Pharmaceuticals llc

05 1Cipla

06 1Encube Ethicals

07 1Lupin Ltd

08 1Padagis

09 1Pfizer Inc

10 1Zydus Lifesciences

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed

TAVABOROLE

Brand Name : TAVABOROLE

Dosage Form : SOLUTION;TOPICAL

Dosage Strength : 5%

Packaging :

Approval Date : 2021-05-07

Application Number : 212215

Regulatory Info : RX

Registration Country : USA

blank

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

TAVABOROLE

Brand Name : TAVABOROLE

Dosage Form : SOLUTION;TOPICAL

Dosage Strength : 5%

Packaging :

Approval Date : 2020-10-21

Application Number : 212188

Regulatory Info : RX

Registration Country : USA

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

TAVABOROLE

Brand Name : TAVABOROLE

Dosage Form : SOLUTION;TOPICAL

Dosage Strength : 5%

Packaging :

Approval Date : 2020-11-25

Application Number : 212256

Regulatory Info : RX

Registration Country : USA

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

TAVABOROLE

Brand Name : TAVABOROLE

Dosage Form : SOLUTION;TOPICAL

Dosage Strength : 5%

Packaging :

Approval Date : 2021-02-03

Application Number : 211963

Regulatory Info : RX

Registration Country : USA

blank

05

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

TAVABOROLE

Brand Name : TAVABOROLE

Dosage Form : SOLUTION;TOPICAL

Dosage Strength : 5%

Packaging :

Approval Date : 2021-02-09

Application Number : 212224

Regulatory Info : RX

Registration Country : USA

blank

06

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

TAVABOROLE

Brand Name : TAVABOROLE

Dosage Form : SOLUTION;TOPICAL

Dosage Strength : 5%

Packaging :

Approval Date : 2020-10-13

Application Number : 211297

Regulatory Info : RX

Registration Country : USA

blank

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

TAVABOROLE

Brand Name : TAVABOROLE

Dosage Form : SOLUTION;TOPICAL

Dosage Strength : 5%

Packaging :

Approval Date : 2021-02-08

Application Number : 212168

Regulatory Info : RX

Registration Country : USA

blank

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

TAVABOROLE

Brand Name : TAVABOROLE

Dosage Form : SOLUTION;TOPICAL

Dosage Strength : 5%

Packaging :

Approval Date : 2020-10-13

Application Number : 211848

Regulatory Info : RX

Registration Country : USA

blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

TAVABOROLE

Brand Name : KERYDIN

Dosage Form : SOLUTION;TOPICAL

Dosage Strength : 5%

Packaging :

Approval Date : 2014-07-07

Application Number : 204427

Regulatory Info : DISCN

Registration Country : USA

blank

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

TAVABOROLE

Brand Name : TAVABOROLE

Dosage Form : SOLUTION;TOPICAL

Dosage Strength : 5%

Packaging :

Approval Date : 2023-04-10

Application Number : 212294

Regulatory Info : RX

Registration Country : USA

blank